Asia Insurance Post
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
Select Page

Regulatory standards must be stronger for quality medicines: Health secy

by AIP Online Bureau | Feb 25, 2025 | Eco/Invest/Demography, Health, Indian News, Policy, Regulation, Risk Management | 0 comments

The meeting with state drug regulators comes in the wake of the Drugs Controller General of India (DCGI) prohibiting the production and export of all combinations of pain relief medicines tapentadol and carisoprodol, following reports that unapproved combinations of these drugs were exported to West African countries by a Mumbai-based pharma firm causing an opioid crisis there

New Delhi: State drug regulators should ensure that medicines are sold only through prescriptions so that narcotic drugs are not diverted for trafficking or other illicit uses, Union Health Secretary Punya Salila Srivastav has said.

Chairing a meeting with state drug regulators to address illicit use of psychotropic drugs under the Nasha Mukt Bharat Abhiyan and strengthen regulatory capacities of states and UTs on Monday, she said regulatory standards need to be strong to ensure that only quality and effective medicines circulate in the country.

During the meeting, Srivastava urged state drug regulators to ensure that medicines are sold only through prescriptions so that narcotic drugs are not diverted for trafficking or other illicit uses.

She also complimented Central Drugs Standard Control Organisation (CDSCO) and state drug regulators for completing risk-based inspections of 905 drug manufacturing and testing firms, resulting in 694 actions being taken so far.

The meeting comes in the wake of the Drugs Controller General of India (DCGI) prohibiting the production and export of all combinations of pain relief medicines tapentadol and carisoprodol, following reports that unapproved combinations of these drugs were exported to West African countries by a Mumbai-based pharma firm causing an opioid crisis there.

Submit a Comment Cancel reply

Your email address will not be published. Required fields are marked *

Recent Posts

  • ICICI Lombard general insurance net profit rises 29% to Rs 747 crore in Q1FY 26
  • ICICI Pru Life Q1 net jumps 34 pc to Rs 302 cr
  • Irdai forms panels to look into violations by insurers
  • General insurers rush to become preferred choices for Tesla’s EV customers in India
  • Rising AI-driven cyber attacks and geopolitical tensions shaping APAC cyber risk landscape, Aon study

Categories

  • Articles
  • Banking & Bancassurance
  • Blog
  • Breaking News!
  • Briefs
  • Climate, Environment, Renewable Energy
  • Data
  • Disaster & Management
  • Eco/Invest/Demography
  • Editorial
  • Events
  • Facts
  • Features
  • Health
  • Indian News
  • Intermediaries
  • International News
  • Interviews
  • Life
  • Main Menu
  • Non-Life
  • Pandemic
  • Pension & Social Security
  • Policy
  • Regulation
  • Reinsurance
  • Risk Management
  • Simple
  • Technology
  • Trends, Facts
  • Uncategorized
  • Wealth Management/ Philanthropy
  • Workplace/Employee Benefits
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
  • Eco/Invest/Demography
  • Indian News
  • International News
  • Health
  • Non-Life
  • Pandemic
  • Technology
  • Risk Management
  • Reinsurance
  • Banking & Bancassurance
  • Wealth Management/ Philanthropy